Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcal polysaccharide vaccine; 23vPPV; hyporesponsiveness; memory BÂ cell; opsonophagocytosis; antibody; CPS; Cell-wall polysaccharide; FiPP; Fiji Pneumococcal Project; MOPA; Multiplexed opsonophagocytic assay; OI; Opsonization index; OPA; Opsonopha
مقالات ISI واکسن مونوژئاز پنوموکوک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: واکسن مونوژئاز پنوموکوک; Streptococcus pneumoniae; Macrolides resistance; ermB; mefE; Pneumococcal conjugate vaccine;
Keywords: واکسن مونوژئاز پنوموکوک; Acute otitis media; Children; Effectiveness; Pneumococcal conjugate vaccine; Serotype; Streptococcus pneumoniae
Keywords: واکسن مونوژئاز پنوموکوک; Invasive pneumococcal disease; Pneumococcal conjugate vaccine; Effectiveness; Case-control study;
Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcal conjugate vaccine; Dot blot; Capillary Western; Simple Western; CRM197; Polysaccharide
Keywords: واکسن مونوژئاز پنوموکوک; EPI; expanded program on immunization; HibCV; Haemophilus influenzae type b conjugate vaccine; NICD; National Institute for Communicable Diseases; NP; nasopharyngeal; NPS; nasopharyngeal swabs; NVT; pneumococcal non-vaccine serotype; PCV; pneumococcal con
Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcal conjugate vaccine; Vaccine clinical evaluation; Immunization; Immunogenicity; AE; adverse event; CI; confidence interval; ELISA; enzyme-linked immunosorbent assay; GMC; geometric mean concentration; Ig; immunoglobulin; IPD; invasive pneumococ
Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcal polysaccharide vaccine; Pneumococcal conjugate vaccine; Nasopharyngeal carriage; Streptococcus pneumoniae; Staphylococcus aureus; Ethnicity;
Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcal conjugate vaccine; Safety; Immunogenicity;
Keywords: واکسن مونوژئاز پنوموکوک; Enfermedad neumocócica invasiva; Incidencia; Vacuna conjugada antineumocócica; Reemplazo de serotipos; Invasive pneumococcal disease; Incidence; Pneumococcal conjugate vaccine; Serotype replacement;
Keywords: واکسن مونوژئاز پنوموکوک; Streptococcus pneumoniae; Invasive pneumococcal disease; Pneumococcal conjugate vaccine; Antibiotic resistance
Keywords: واکسن مونوژئاز پنوموکوک; Georgia; Cost-effectiveness analysis; Pneumococcal conjugate vaccine; Decision-making process; Evidence-based medicine;
Keywords: واکسن مونوژئاز پنوموکوک; AES; acute encephalitis syndrome; AFP; acute flaccid paralysis; AMES; acute meningitis-encephalitis syndrome; BNG; Bangladesh; CHN; China; CSF; cerebrospinal fluid; ELISA; enzyme-linked immunosorbent assay; GFIMS; Global Framework for Immunization Monitor
Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcal disease; Pneumococcal polysaccharide vaccine; Pneumococcal conjugate vaccine; Indigenous; Invasive pneumococcal disease epidemiology;
Keywords: واکسن مونوژئاز پنوموکوک; DHS; Demographic and Health Surveys; DTP; diphtheria, pertussis, and tetanus; DTwP; diphtheria, tetanus, and whole-cell pertussis; EPI; Expanded Programme on Immunization; hepB; hepatitis B; Hib; Haemophilus influenzae type B; IQR; interquartile range; MC
Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcal conjugate vaccine; Cost effectiveness; Paraguay;
Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcal conjugate vaccine; Cost effectiveness; Disability adjusted life years; Children; Peru;
Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcal disease; Pneumococcal conjugate vaccine; Invasive pneumococcal disease; Pneumococcal meningitis; Pneumococcal pneumonia;
Keywords: واکسن مونوژئاز پنوموکوک; PCVs; pneumococcal conjugate vaccines; PCV7; 7-valent pneumococcal conjugate vaccine; PCV10; 10-valent pneumococcal conjugate vaccine; PCV13; 13-valent pneumococcal conjugate vaccine; Pneumococcal conjugate vaccine; Streptococcus pneumoniae; Cost-effectiv
Keywords: واکسن مونوژئاز پنوموکوک; Streptococcus pneumoniae; Serotype; Pneumococcal conjugate vaccine; Antibiotic resistance; Children
Keywords: واکسن مونوژئاز پنوموکوک; Community-acquired pneumonia; disease burden; elderly; incidence; invasive pneumococcal disease; outcome; pneumococcal conjugate vaccine; pneumococcal pneumonia; Streptococcus pneumoniae
Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcal conjugate vaccine; Streptococcus pneumoniae; Invasive pneumococcal disease; Public health surveillance; Impact;
Keywords: واکسن مونوژئاز پنوموکوک; pneumococcal conjugate vaccine; Streptococcus pneumoniae; vaccination schedule adherence; vaccine uptake;
Keywords: واکسن مونوژئاز پنوموکوک; Diagnosis; Paediatrics; Pneumococcal conjugate vaccine; Pneumonia; Serotype; Streptococcus pneumoniae; Urinary pneumococcal antigen;
Keywords: واکسن مونوژئاز پنوموکوک; Streptococcus pneumoniae; Invasive pneumococcal disease; Pneumococcal conjugate vaccine; Antibiotic resistance; Multiplex PCR;
Keywords: واکسن مونوژئاز پنوموکوک; Adolescents; Asthma; Children; Pneumococcal conjugate vaccine; Pneumococcal vaccine; Streptococcus pneumoniae;
Keywords: واکسن مونوژئاز پنوموکوک; PCV; pneumococcal conjugate vaccine; VEcol; vaccine efficacy against colonisation; VEacq; vaccine efficacy against acquisition of colonisation; VET; combined vaccine efficacy against acquisition and duration of colonisation; VT; vaccine (sero)type(s); NVT
Keywords: واکسن مونوژئاز پنوموکوک; PCV13; Streptococcus pneumoniae; Pneumococcal conjugate vaccine; Serotype replacement; Invasive pneumococcal disease; Prevnar 13;
Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcal conjugate vaccine; Vaccine safety; Surveillance; Group sequential analysis;
Keywords: واکسن مونوژئاز پنوموکوک; OR; odds ratio; PCV; pneumococcal conjugate vaccine; VEcol; vaccine efficacy against colonisation; VEacq; vaccine efficacy against acquisition of colonisation; VET; combined vaccine efficacy against acquisition and duration of colonisation; VT; vaccine (s
Keywords: واکسن مونوژئاز پنوموکوک; Streptococcus pneumoniae; Serotype; Prevenar; Invasive pneumococcal disease; Pneumococcal conjugate vaccine; Antibiotic resistance;
Keywords: واکسن مونوژئاز پنوموکوک; Vaccine safety; French national health insurance regime information system; Pharmacoepidemiology; Measles/mumps/rubella vaccine; Febrile convulsions; Self controlled case series; MMR; measles/mumps/rubella; PCV; pneumococcal conjugate vaccine; SCCS; self-
Keywords: واکسن مونوژئاز پنوموکوک; Streptococcus pneumoniae; Pneumococcal conjugate vaccine; Dosing schedules; HIV; Opsonophagocytic assay;
Keywords: واکسن مونوژئاز پنوموکوک; AE; adverse event; CI; confidence interval; CRM197; cross-reactive material 197; GMR; geometric mean ratio; GMT; geometric mean titer; IPD; invasive pneumococcal disease; LLOQ; lower limit of quantitation; LOD; limit of detection; OPA; opsonophagocytic ac
Keywords: واکسن مونوژئاز پنوموکوک; ACIP; United States Advisory Committee on Immunization Practices; AE; adverse event; CI; confidence interval; CRM197; cross-reactive material 197; GMR; geometric mean ratio; GMT; geometric mean titer; OPA; opsonophagocytic activity; PCV; pneumococcal poly
Keywords: واکسن مونوژئاز پنوموکوک; Streptococcus pneumoniae; Pneumococcal conjugate vaccine; PCV7; Opsonophagocytosis; Avidity; Booster vaccination;
Keywords: واکسن مونوژئاز پنوموکوک; 2+1; PCV13; Immune response; Pediatric; Pneumococcal conjugate vaccine;
Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcal conjugate vaccine; Vaccination programme; Cost-effectiveness analysis; QALY;
Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcal conjugate vaccine; Safety; Immunogenicity; Meta-analysis;
Keywords: واکسن مونوژئاز پنوموکوک; Streptococcus pneumoniae; Pneumococcal; Antibiotic resistance; Pneumococcal conjugate vaccine; PCV7; Pneumococcal serotypes;
Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcus; Pneumococcal conjugate vaccine; Indirect effect; Nasopharyngeal colonization; Nasopharyngeal carriage;
Keywords: واکسن مونوژئاز پنوموکوک; cMYP; comprehensive, multi-year plan for immunization; EMRO; WHO Eastern Mediterranean Regional Office; GNI; gross national income; GVAP; Global Vaccine Action Plan; Hib; Haemophilus influenzae type B; HPV; human papillomavirus; LIC; low-income country; L
Keywords: واکسن مونوژئاز پنوموکوک; Community-acquired pneumonia; Invasive pneumococcal disease; PCV13; Pneumococcal conjugate vaccine; Persistence of vaccine efficacy
Keywords: واکسن مونوژئاز پنوموکوک; Community-acquired pneumonia; Children; Radiological pneumonia; Surveillance; Chest X-ray; Pneumococcal conjugate vaccine
Keywords: واکسن مونوژئاز پنوموکوک; Streptococcus pneumoniae; Carriage; Children; Pneumococcal conjugate vaccine; Serotype; Antimicrobial resistance
Serotype distribution of invasive Streptococcus pneumoniae in adults 65â¯years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016
Keywords: واکسن مونوژئاز پنوموکوک; Streptococcus pneumoniae; Pneumococcus; Invasive pneumococcal disease; Serotype; Surveillance; Adults; Pneumococcal conjugate vaccine; Herd immunity; Antimicrobial resistance;
Reduced nontypeable Haemophilus influenzae lower airway infection in children with chronic endobronchial suppuration vaccinated with the 10-valent pneumococcal H. influenzae protein D conjugate vaccine
Keywords: واکسن مونوژئاز پنوموکوک; BAL; bronchoalveolar lavage; CFU; colony-forming units; CI; confidence interval; CSLD; chronic suppurative lung disease; HR; hazard ratio; HRCT; high-resolution computed tomography; NP; nasopharyngeal; NT; Northern Territory; NTHi; nontypeable Haemophilus
Safety and immunogenicity of the Cuban heptavalent pneumococcal conjugate vaccine in healthy infants. Results from a double-blind randomized control trial Phase I
Keywords: واکسن مونوژئاز پنوموکوک; Pneumococcal conjugate vaccine; Immunogenicity; Safety; Infant; Clinical trial; Cuban;
Distribution of invasive Streptococcus pneumoniae serotypes before and 5â¯years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil
Keywords: واکسن مونوژئاز پنوموکوک; Streptococcus pneumoniae; Pneumococcal serotypes; Pneumococcal conjugate vaccine; 10-valent pneumococcal conjugate vaccine;
Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9â¯years of pneumococcal conjugate vaccine programme
Keywords: واکسن مونوژئاز پنوموکوک; AOM; acute otitis media; CRO; clinical research organisation; Chi2; Chi-Square test; DCC; day-care centre; GP; general practitioner; IPD; invasive pneumococcal disease; MWU; Mann-Whitney U test; NP; nasopharyngeal; PCV; pneumococcal conjugate vaccine; STG